期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Virology Journal LetPub Score 6.4
50 ratings
Rate
Reputation 7.1 Influence 5.2 Speed 9.2 | ||||||||||||||||||||
期刊簡稱 | VIROL J | ||||||||||||||||||||
ISSN | 1743-422X | ||||||||||||||||||||
h-index | 70 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 2.50%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://virologyj.biomedcentral.com | ||||||||||||||||||||
在線稿件提交 | https://submission.nature.com/new-submission/12985/3 | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||
發行頻率 | 不定期刊行 | ||||||||||||||||||||
創刊年 | 2004 | ||||||||||||||||||||
每年文章數 | 297每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 99.74% | ||||||||||||||||||||
OA Related Info | APC: Yes( GBP2390; USD3190; EUR2690; ) APC waiver:Check Notes Other charges: No Keywords: human viruses、plant viruses、antiviral agents、vaccines、animal viruses、infection control Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1743-422X%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 1.0 month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 83.33% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 | |
[Virology Journal] 的評論 | 撰寫評論 |
作者: mina! 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-30 09:09:33 評論於 Why hasn't the review started after half a month of submission? It has been in the hands of the editor all this time. Is there no one reviewing it? How long does it typically take for everyone with the editor?(0) 讚! | mina! |
作者: Jenny_Wang 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-12-31 13:47:28 評論於 10.8 Submission 11.15 Received revision comments (reviewed for about 5 weeks) 11.28 Submitted revised draft (submitted for a second time due to errors) 12.6 Resubmitted revisions 12.21 Received acceptance letter Review comments were very professional, detailed, and communication with the editor via email was smooth~(0) 讚! | Jenny_Wang |
作者: 格里菲斯菲利浦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-22 12:48:42 評論於 Yes(0) 讚! | 格里菲斯菲利浦 |
作者: 落英涵露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-27 17:41:14 評論於 Is there a traditional subscription fee for this journal? All pages required a fee?(0) 讚! | 落英涵露 |
作者: 百花怡嘉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-20 10:34:11 評論於 How much is the layout fee?(0) 讚! | 百花怡嘉 |
作者: Alberta Bobby 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-16 19:58:08 評論於 It's been over a month(0) 讚! | Alberta Bobby |
作者: Alberta Bobby 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-02 16:14:23 評論於 Pretty fast(0) 讚! | Alberta Bobby |
作者: Daniel Lawrence 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-11 08:52:16 評論於 When did you invest?(0) 讚! | Daniel Lawrence |
作者: 暴风嘉赐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-27 23:16:13 評論於 This magazine is really slow(0) 讚! | 暴风嘉赐 |
作者: 老刘 領域: 医学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-08-10 14:40:05 評論於 At the beginning, the data in hand was divided into three parts and published separately. The first submission to JMV was rejected. Due to the need to graduate, all the data was used, and the bioinformatics and visualization were done quite well.(0) 讚! | 老刘 |
作者: 老刘 領域: 医学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-08-10 14:38:22 評論於 Direct recruitment has been confirmed. When I saw the review result after more than a month, I thought I had failed again... but to my surprise, it was an acceptance. Now the impact factor is approaching 6 points. Keep up the good work!(0) 讚! | 老刘 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:47:43 評論於 The list of SCI Quartile Rankings at the Chinese Academy of Sciences is still an indispensable reference directory for the research performance rewards and title evaluations of many domestic universities and research institutes(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-29 23:11:48 評論於 How are SCI journals divided?(0) 讚! | 龙鳞孝礼 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 11:54:12 評論於 Do publications need to be based on sections when selecting?(0) 讚! | 北国博达 |
作者: 珉林铃语 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-22 16:27:00 評論於 Review speed: 2.0 | Submission hit rate: 50.0 | Layout fee: 2500.0 Emphasized research direction: data mining; covid-19 Experience sharing: Clinical data mining and modeling of COVID-19, with independent validation data, totaling more than 300 cases. The manuscript was submitted in September last year, with two reviewers, one of whom asked many questions and required a lot of additional calculations. It underwent major revisions and an extension of one month, finally revised in early January. However, there was no response afterwards despite sending emails to urge for updates. It is suspected whether the previous reviewer encountered any issues. Until a new editor took over the handling and shortly after, the paper was accepted. Fortunately, the Impact Factor was 2.5 when submitted last year, and it increased to 4.1 this year, nice!(0) 讚! | 珉林铃语 |
作者: 霸王奇略 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-15 16:04:45 評論於 Do you need the original data? Does WB need the original image?(0) 讚! | 霸王奇略 |
作者: zhaowuma 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-09-18 22:17:56 評論於 The review speed was average, which was one month and a half. After the submission of the revised manuscript, it was soon accepted. It was about the bioinformatics analysis of the virus, there was no experiment made, but it was published, However, the publication fee is too high, $2,500, which is indeed a bit expensive. (0) 讚! | zhaowuma |
作者: 北陆恒菽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-30 13:40:30 評論於 Are you under review for two months or with the editor for two months?(0) 讚! | 北陆恒菽 |
作者: 明冠乐天 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-29 16:30:20 評論於 The first trial had to wait at least two months. I couldn't hold on anymore, but the result was accepted directly, which was unexpected(0) 讚! | 明冠乐天 |
作者: 归元少杰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-23 19:08:29 評論於 How is it going editor invited for almost a month? I am really worried. qikeqike0607 2016-06-22 Published: SCI(2015): 2.362 SCI(2014): 2.181 I submitted on June 14th, and now it is in the "being processed" stage. In my view reference checking result, there are 6 articles that are not validated. What should I do? Any seniors who have encountered this situation please advise, thank you(0) 讚! | 归元少杰 |
作者: 归元少杰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-21 14:54:23 評論於 Is this magazine very slow? It's been almost a month since the editor invited, but it still hasn't been under review. I'm really worried(0) 讚! | 归元少杰 |
作者: 明冠乐天 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-20 13:43:02 評論於 Already online, very smooth(0) 讚! | 明冠乐天 |
作者: 明冠乐天 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-02 18:07:29 評論於 Review speed: 3.0 | Submission success rate: 50.0 Sharing experience: I submitted my work three months ago and hadn't heard anything. Today I received an email saying it was accepted. I'm so happy! The editor asked for an editable file. Has anyone else experienced this?(0) 讚! | 明冠乐天 |
作者: Bradley Mathilda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-11-14 17:25:34 評論於 Which one did you invest in later? It was crazy that you got rejected, but you saved a lot of money by investing in other things instead!(0) 讚! | Bradley Mathilda |
作者: 销魂怡冉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-10 19:02:06 評論於 I was rejected unexpectedly, but luckily won in other places, saving a lot of money! Feng Feng Wang 2019-01-06 00:00:00 Posted: under review, hopefully they won't be too hard on me(0) 讚! | 销魂怡冉 |
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 |
Contact us